4 weeks Celldex Therapeutics’ (CLDX) Buy Rating Reiterated at HC WainwrightMarketBeat
HC Wainwright reissued a “buy” rating and set a $80.00 price objective on shares of Celldex Therapeutics in a research note on Monday.
XHC Wainwright reissued a “buy” rating and set a $80.00 price objective on shares of Celldex Therapeutics in a research note on Monday.
X